FAC Explorer

Audit 27281

FY End
2022-06-30
Total Expended
$2.31M
Findings
0
Programs
6
Organization: Exponents, Inc. (NY)
Year: 2022 Accepted: 2023-03-08
Auditor: Condon O'Meara McGinty and Donnelly LLP

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.914 Hiv Emergency Relief Project Grants $591,016 - 0
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $214,436 Yes 0
93.788 Opioid Str $120,863 - 0
93.940 Hiv Prevention Activities_health Department Based $104,494 - 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $54,168 - 0
93.498 Provider Relief Fund $10,034 - 0

Contacts

Name Title Type
C1B7W5VZ89L1 Regina Edwards Auditee
2122433434 John Daum Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Basis of presentationThe accompanying schedule of expenditures of federal awards (the Schedule) includes the activities in all the Federal programs of Exponents, Inc. and is presented on the accrual basis of accounting. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirement, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Schedule may differ from amounts presented in, or used in the preparation of, the financial statements.Indirect cost rateThe Agency has an approved indirect cost rate and therefore has elected not to use the 10 percent de minimus indirect cost rate allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.